Analysis of Lymphocyte Immunological Reactivity in Patients with Pleural Effusions of Different Etiology

  • Zlatica Goseva University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Biserka Jovkovska Kaeva University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Angelko Gjorcev University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Elena Jovanovska Janeva University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Zoran Arsovski University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Sava Pejkovska University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
  • Aleksandra Tatabitovska University Clinic of Pulmonology and Allergology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje
Keywords: pleural effusions, lymphocyte, CD markers, malignant pleural fluid, tuberculous pleural effusions

Abstract

BACKGROUND: The proportion of T and B lymphocytes in pleural fluids and blood may point to the presence of local immunological phenomena in pleural disorders.

AIM: Aim of study was to evaluate the lymphocyte phenotype and the ratio between helper (CD4+) and cytotoxic/suppressor (CD8+) lymphocytes in malignant and non-malignant effusions.

MATERIAL AND METHODS: We studied 48 patients with pleural effusions. First group had 18 patients with tuberculosis pleural effusions; second group had 20 patients with malignant pleural fluids, third group had 10 patients with transudates and 30 healthy controls. We investigated the distribution of T and B lymphocytes, T cells with helper/inducer CD4 or suppresser/cytotoxic CD8 phenotypes and the CD16 subset.

RESULTS: Results showed decreases levels of CD3, CD4, and CD16 T cells in blood of patients versus healthy controls. There were increases in the percentage of the CD3 and CD4 T cells in the pleural fluid compared with values in the blood with statistical significance in tuberculous pleurisy. The values of CD8 were similar in the pleural fluid and in blood. Levels of CD16 were non-significantly higher in pleural fluid in all groups.

CONCLUSION: This study confirms the hypothesis that pleural cavity is compartment with immunological reactivity and results could be used in differential diagnosis together with other examinations.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Dalbeth N, Lee YCG. Lymphocytes in pleural disease. Current Opinion in Pulmonary Medicine. 2005;11(4):334-339.

http://dx.doi.org/10.1097/01.mcp.0000166490.92659.17

PMid:15928502

Aguiar LMZ de, Antonangelo L, Vargas FS, Zerbini MCN, Sales MM, Uip DE, Saldiva PHN. Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization. Clinics. 2008;63(5):637-44.

http://dx.doi.org/10.1590/S1807-59322008000500012

PMCid:PMC2664722

Kochman S, Bernard J, Lavaud F, Cazabat A, Dubois Montreynaud JM. T lymphocyte subsets in pleural fluids: discrimination according to traditional and monoclonal antibody-defined markers. Eur J Resp Dis. 1984;65:586-591.

PMid:6240409

Lucivero G, Pierucci G, Bonamo L. Lymphocyte subsets in peripheral blood and pleural fluid. Eur Resp J. 1988;1:337-340.

PMid:3260873

Valdés L, Pose A, San José E, Martínez Vázquez JM. Tuberculous pleural effusions. Eur J Intern Med. 2003;14(2):77-88.

http://dx.doi.org/10.1016/S0953-6205(03)00018-9

Masakazu O,Yoshinori H, Toru H, Naozumi H, Kazuyoshi I, Kaoru Sh, Tsutomu K. T-Helper Type 1/T-Helper Type 2 Balance in Malignant Pleural Effusions Compared to Tuberculous Pleural Effusions. CHEST. 2005;128:4030–4035.

http://dx.doi.org/10.1378/chest.128.6.4030

PMid:16354877

Atanackovic Dj, Block A, De Weerth A, Faltz C, Hossfeld DK, Hegewisch-Becker S. Characterization of Effusion-Infiltrating T Cells: Benign versus Malignant Effusions. Clinical Cancer Research. 2004;10:2600–2608.

http://dx.doi.org/10.1158/1078-0432.CCR-03-0239

Shiratsuchi H, Tsuyguchi J. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivate of tuberculin. Clin Exp Immunol. 1984; 57:271-278.

PMid:6331920 PMCid:PMC1536122

Ghosha AG, Mukherjee K, Saha AK, Chowdhury TK. Compartmentalisation of lymphocytes in tuberculous pleural effusion: a preliminary observation. Ind J Tub. 1996;43:23.

Klimiuk J, Domagała-Kulawik J, Krenke R, Chazan R. Lymphocyte and lymphocyte subsets in pleural fluid - comparison of malignant and non-malignant disorders. Pol Arch Med Wewn. 2004; 111(3):291-6.

PMid:15230209

Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rea TH, Modlin RL. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol. 1989;142(4):1114-9.

PMid:2464638

Trajman A, Pai M, Dheda K, van Zyl Smit R, Zwerling AA, Joshi R, Kalantri S, Daley P, Menzies D. Novel tests for diagnosing tuberculous pleural effusion: what works and what does not? Eur Respir J. 2008;31(5):1098-106.

http://dx.doi.org/10.1183/09031936.00147507

PMid:18448504

Tong ZH, Shi HZ. Subpopulations of helper T lymphocytes in tuberculous pleurisy. Tuberculosis. 2013;93(3):279-84.

http://dx.doi.org/10.1016/j.tube.2013.02.014

PMid:23477939

San José ME, Valdés L, Saavedra MJ, De Vega JM, Alvarez D, Vi-uela J, Penela P, Valle JM, Seoane R. Lymphocyte populations in tuberculous pleural effusions. Ann Clin Biochem. 1999;36(Pt 4):492-500.

http://dx.doi.org/10.1177/000456329903600413

PMid:10456212

Qin XJ, Shi HZ, Liang QL, Huang LY, Yang HB. CD4+CD25+ regulatory T lymphocytes in tuberculous pleural effusion. Chin Med J (Engl). 2008;121(7):581-6.

Robinson E, Segal R, Vesely Z. Lymphocyte subpopulation in peripheral blood and malignant effusions of cancer patients. Eur J Cancer Clin Oncol. 1986;22(2):191-193.

http://dx.doi.org/10.1016/0277-5379(86)90029-5

Chen YQ, Shi HZ, Qin XJ, Mo WN, Liang XD, Huang ZX, Yang HB, Wu C. CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion. Am J Respir Crit Care Med. 2005;172(11):1434-9.

http://dx.doi.org/10.1164/rccm.200504-588OC

PMid:16151041

Michael RS, David WE. T lymphocytes and pleural tuberculosis. Chest. 1986;89:4.

Scherpereel A, Grigoriu BD, Noppen M, Gey T, Chahine B, Baldacci S, Trauet J, Copin MC, Dessaint JP, Porte H, Labalette M. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid. BMC Cancer. 2013;13:324.

http://dx.doi.org/10.1186/1471-2407-13-324

PMid:23816056 PMCid:PMC3718618

Onishi H, Morisaki T, Kuga H, Katano M, Doi F, Uchiyama A, Sugitani A, Wada J, Chijiiwa K, Tanaka M. A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma. Immunol Invest. 2002;31(2):121-35.

http://dx.doi.org/10.1081/IMM-120004803

PMid:12148948

Published
2015-12-25
How to Cite
1.
Goseva Z, Jovkovska Kaeva B, Gjorcev A, Jovanovska Janeva E, Arsovski Z, Pejkovska S, Tatabitovska A. Analysis of Lymphocyte Immunological Reactivity in Patients with Pleural Effusions of Different Etiology. Open Access Maced J Med Sci [Internet]. 2015Dec.25 [cited 2020Dec.2];4(1):50-3. Available from: https://www.id-press.eu/mjms/article/view/oamjms.2016.009
Section
B - Clinical Sciences